
USD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$2.21B
Market Cap
-
P/E Ratio
-0.23
EPS
$48.04
52 Week High
$21.97
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $249M |
| Total Revenue | $389M |
| Cost Of Revenue | $140M |
| Costof Goods And Services Sold | $140M |
| Operating Income | $39M |
| Selling General And Administrative | $191M |
| Research And Development | $28M |
| Operating Expenses | $210M |
| Investment Income Net | - |
| Net Interest Income | -$33M |
| Interest Income | $1.5M |
| Interest Expense | $34M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $24M |
| Income Before Tax | -$7.5M |
| Income Tax Expense | $5.8M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$13M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $27M |
| Ebitda | $51M |
| Net Income | -$13M |
| Field | Value (USD) |
|---|---|
| Total Assets | $789M |
| Total Current Assets | $290M |
| Cash And Cash Equivalents At Carrying Value | $53M |
| Cash And Short Term Investments | $53M |
| Inventory | $80M |
| Current Net Receivables | $86M |
| Total Non Current Assets | $499M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $156M |
| Intangible Assets Excluding Goodwill | $156M |
| Goodwill | $241M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $71M |
| Other Non Current Assets | - |
| Total Liabilities | $513M |
| Total Current Liabilities | $67M |
| Current Accounts Payable | $18M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $5.3M |
| Total Non Current Liabilities | $446M |
| Capital Lease Obligations | $48M |
| Long Term Debt | $314M |
| Current Long Term Debt | $195K |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $362M |
| Other Current Liabilities | $41M |
| Other Non Current Liabilities | $61M |
| Total Shareholder Equity | $276M |
| Treasury Stock | - |
| Retained Earnings | -$61M |
| Common Stock | $434K |
| Common Stock Shares Outstanding | $42M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $22M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $24M |
| Capital Expenditures | $11M |
| Change In Receivables | - |
| Change In Inventory | -$6.1M |
| Profit Loss | - |
| Cashflow From Investment | -$28M |
| Cashflow From Financing | $2.2M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | $0 |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$13M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $249M |
| Total Revenue | $389M |
| Cost Of Revenue | $140M |
| Costof Goods And Services Sold | $140M |
| Operating Income | $39M |
| Selling General And Administrative | $191M |
| Research And Development | $28M |
| Operating Expenses | $210M |
| Investment Income Net | - |
| Net Interest Income | -$33M |
| Interest Income | $1.5M |
| Interest Expense | $34M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $24M |
| Income Before Tax | -$7.5M |
| Income Tax Expense | $5.8M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$13M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $27M |
| Ebitda | $51M |
| Net Income | -$13M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2015-12-09 |
| Declaration Date | None |
| Record Date | None |
| Payment Date | None |
| Amount | 0.03 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Artivion Inc. is a pioneering leader in the field of implantable human tissues and advanced medical devices, dedicated to enhancing surgical outcomes and improving patient care worldwide. With a strong focus on tissue bioengineering and regenerative medicine, the company is at the forefront of innovation, delivering high-quality solutions that meet the evolving demands of the healthcare sector. Artivion's commitment to continuous improvement and excellence positions it as a key player in the medical technology landscape, effectively addressing the pressing needs for sustainable and effective surgical interventions.